Table 2.

Antifungal susceptibilities of the Candida dubliniensis type strain (CD36) and of strains with decreased susceptibilities to fluconazole tested against triazole and echinocandin antifungal agents

IsolateAntifungal agentMIC (μg/ml)
CD36Fluconazole0.25
Itraconazole0.06
BMS-2071470.008
Sch 565920.03
Voriconazole0.03
MK-09910.25
CD36-70Fluconazole64
Itraconazole0.12
BMS-2071470.06
Sch 565920.06
Voriconazole0.5
MK-09910.12
CD51-IIAFluconazole32
Itraconazole0.06
BMS-2071470.03
Sch 565920.06
Voriconazole0.25
MK-09910.06
CD51-IIBFluconazole32
Itraconazole0.12
BMS-2071470.06
Sch 565920.12
Voriconazole0.5
MK-09910.25
CD51-IICFluconazole64
Itraconazole0.25
BMS-2071470.06
Sch 565920.12
Voriconazole0.5
MK-09910.03
CD57-BFluconazole32
Itraconazole0.5
BMS-2071470.25
Sch 565920.25
Voriconazole0.25
MK-09910.25